John Kelly

For over 20 years, John Kelly was into developing and commercialising medical devices to enhance usability and performance, having started with CR Bard in Europe developing Class III implantable cardiology products.

Prior to co-founding Atomo in September 2009, Mr Kelly acted as the chief operating officer of Unilife Corporation which was previously an ASX-listed company and subsequent to his departure, a Nasdaq-listed company. At Unilife Corporation, he led the global operations team from 2005 to 2008, developing 'Unifill'. Prior to Unilife in 2005, Mr Kelly spent five years at ResMed where he led the new product implementation group and managed the development of Mirage Swift & Activa mask systems.